Please login to the form below

Not currently logged in
Email:
Password:

Consilium wins Allergy Therapeutics account

Will advise the firm on international investor relations

Consilium Strategic CommunicationsConsilium Strategic Communications has been appointed by specialty pharmaceutical firm Allergy Therapeutics as its international investor relations advisor.

The healthcare agency will support Allergy Therapeutics' international financial and corporate public relations activities as it seeks to step up its international stakeholder activities.

Consilium's Mary-Jane Elliott, Chris Gardner, Ivar Milligan, Matthew Neal and Laura Thornton have been tasked with raising the European allergy product company's global profile, particularly focusing on the US.

Commenting on the Consilium advisory team, Allergy Therapeutics' chief executive officer Manuel Llobet said: “This team's expertise and knowledge of the sector is unrivalled and they have already demonstrated this through their high quality advice, proactivity and professionalism.”

Elliott, co-founder and managing partner at Consilium, said: “We are delighted to be advising Allergy Therapeutics at a time when they are on a steep growth trajectory due to a strong portfolio of marketed products and M&A.

“We look forward to accompanying them on their journey as they pave the way to the US market and further international growth.”

Article by
Rebecca Clifford

7th March 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Spirit, an OPEN Health Company

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...